Tevogen Bio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -99 | -98 |
EBITDA | -8,599 | 11,518 |
EBIT | -8,599 | 11,420 |
Net Income | -9,663 | 11,264 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -2,982 | -2,163 |
Cash | 1,135 | 1,317 |
Basic Shares | 154,167 | 142,387 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | 188 | -953 | -28 |
EBIT | -8 | -1,183 | -38 |
Net Income | -67 | 4,408 | -15,596 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,376 | -694 | -5,384 |
Cash | 8 | 129 | 7,119 |
Basic Shares | 165,421 | 119,999 | 119,999 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.03 |
2024-03-31 | -$0.26 |
2023-12-31 | -$0.05 |
2023-09-30 | -$0.01 |
